PGY2 Oncology Residency Structure

PGY2 Oncology Residency Structure

Orientation

In addition, the resident will be oriented to the evaluation process and the PharmAcademic online evaluation system (if not utilized during PGY1 residency). Eligibility for Pharmacist Licensure in the State of Texas and licensure deadlines must be adhered to as outlined in the Residency Licensure Policy.

Departmental and residency training will include orientation to policies and procedures, University Health computers, and the outpatient clinics and pharmacies. The resident will also be oriented to the ASHP Residency Accreditation Standards, Program Design and Conduct, and the required Competency Areas, Goals, and Objectives for PGY2 residency training. In addition, the resident will be oriented to the evaluation process and the PharmAcademic online evaluation system (if not utilized during PGY1 residency).

The resident must become licensed in the State of Texas as a Registered Pharmacist as outlined in licensure policy.

Academic Pharmacotherapy

The resident will participate in The University of Texas College of Pharmacy residents’ weekly Pharmacotherapy Seminar on Friday afternoons. The resident will be required to lead the discussion on at least one oncology topic, as assigned by the group coordinator.

The University of Texas College of Pharmacy residents’ weekly Pharmacotherapy Rounds, also on Friday afternoons, will be attended by the resident. This activity is required unless it interferes with urgent, necessary patient care obligations. The resident will also be required to present one formal Pharmacotherapy Rounds (“Resident Rounds”) during the year.

Other required academic activities include hematology/oncology topic discussions, journal clubs and facilitating labs for pharmacy students. The resident will assist preceptors in mentoring and precepting pharmacy students assigned to internal medicine rotations.

The resident may elect to obtain an Academic Training Program Certificate through The University of Texas College of Pharmacy. The University of Texas College of Pharmacy Teaching and Leadership Fellows (TLFP) requirements will be completed throughout the year, including attendance at the UT Academic Training Conference.

Practice Management

The resident is required to attend and actively participate in scheduled monthly Residency Advisory Council (RAC) meetings, Pharmacy & Therapeutics (P&T) meetings, Medication Safety Committee meetings and quarterly Drug Utilization Evaluation (DUE) Committee meetings throughout the year. The resident will also be a non-voting member of a hematology/oncology P&T subcommittee.

The resident is expected to present oncology-related topics when needed at these meetings. Learning opportunities may include:

  1. Organizing and coordinating a P&T Subcommittee meeting
  2. Organizing and coordinating RAC meetings for a portion of the year designated by the RPD
  3. Conducting an oncology-related DUE
  4. Preparing or revising a treatment guideline or protocol
  5. Presenting results of research projects at DUE, P&T and/or pharmacy meetings

Examples of internal medicine-related topics that may be addressed include:

  1. Formulary and fiscal management
  2. Pharmacy policies and procedures
  3. Medication-related guidelines/protocols
  4. Information technology and automation systems
  5. Medication-use system evaluation
  6. Adverse drug reaction reporting, trending and interpretation
  7. Medication safety and medication error reporting, trending and prevention
  8. Pharmacist intervention reporting and trending
  9. Investigational drugs

The resident will have the opportunity to attend and participate in local, state and national professional association meetings, including but not limited to the ASHP Midyear Clinical Meeting, Hematology/Oncology Pharmacy Association Annual Meeting and Celebrating Pharmacy Research Excellence Day.

Clinical Practice

The resident will provide clinical staffing from August to June, occurring every 3rd weekend as scheduled by the RPD, not to exceed 16 hours per 2-week period.

Professional Development

This longitudinal rotation is structured to provide the resident experience in self-evaluation of their strengths, goals, progress throughout the residency, and areas for improvement. Self-evaluations will be completed and discussed between the resident and residency leadership on a quarterly basis, then incorporated into each resident’s personal development plan.

Research Project

Successful completion of at least one research project is required to fulfill the requirements and to obtain a certificate of graduation from the residency program. The resident must adhere to the established timeline for the project to ensure successful completion during the one-year residency.

The research project topic may be an idea by the resident, selected from a suggested list or assigned individually. The project will be directly supervised by the RPD, Residency Coordinator and/or a preceptor with expertise in the selected discipline. The research project proposal must be approved by the RPD/Coordinator and, if applicable, must also be approved by the UT Health San Antonio Investigational Review Board and the University Health Research Committee.

The research project will be presented as an abstract/poster at the Hematology/Oncology Pharmacy Association Annual Meeting.

The research project must also be submitted in manuscript form to the RPD/Residency Coordinator, and the resident is strongly encouraged to publish the results of the project in a peer-reviewed journal.

Rotations

The length of each rotation is usually one month, but may be flexible, depending on the needs and interests of the individual resident. The following rotations are required:

  • Inpatient Hematology I
  • Inpatient Medical Oncology I
  • Gynecology Oncology
  • Pediatric Hematology/Oncology I
  • Infusion Center I
  • Inpatient Bone Marrow Transplant

Other rotations available on a selective or elective basis include but are not limited to the following:

  • Inpatient Hematology II (Selective)
  • Inpatient Medical Oncology II (Selective)
  • Breast Oncology Clinic
  • Hematology Clinic
  • Gynecology Oncology Clinic
  • Pediatric Oncology II
  • Infusion Center II
  • Oral Chemotherapy
  • Palliative Care
  • Administration
  • Academia